Battery Life Can Help Save a Life – Energizer® supports Diabetes Australia 21 May 2019 Energizer Australia Pty. Ltd. (“Energizer”) will support National Diabetes Week for the fourth year in a row and will donate $1 from the purchase of every specially marked pack of Energizer® batteries to Diabetes Australia to support the organisation’s life-changing work. The money raised will help Diabetes Australia assist people living with diabetes and fund critical diabetes research through the Diabetes Australia Research Program. The Program funds diabetes research into all facets of diabetes including, hopefully, a cure. Energizer has a 120 year history of innovation in batteries and is currently the maker of the world’s longest lasting AA battery (Energizer® Ultimate Lithium™). Diabetes Australia CEO Professor Greg Johnson welcomed Energizer’s support of National Diabetes Week for a fourth consecutive year. “It is wonderful that Energizer is once again supporting Diabetes Australia in our efforts to raise awareness of diabetes and the need for more funding to support diabetes research,” Professor Greg Johnson said “Diabetes Australia is a charity and relies on long term support like this which is vital to sustaining our efforts.” “A cure for diabetes remains the ultimate goal – and our national research program brings us closer each day to a breakthrough.” Energizer business director David Pattison said the company was committed to supporting people with diabetes. “We are proud to stand with Diabetes Australia on their journey for a better future for people living with diabetes,” Mr Pattinson said. This National Diabetes Week, support life-saving research by buying a long lasting battery and improving the lives of people living with diabetes. Your purchase will support Diabetes Australia supporting Australia’s diabetes community. Keep an eye out for the Energizer® battery packs with $1 donation stickers in stores near you.
Blog 18 November 2026 Make a splash: Water exercise for diabetes As the weather warms up, it can be less enticing to go for that walk or bike ride, so why... Continue Reading
Media releases 18 November 2026 Foundayo approval a welcome addition to GLP-1 treatment options Diabetes Australia has welcomed the TGA approval of Foundayo (orforglipron), a new oral GLP-1 receptor agonist for the management of type 2 diabetes and chronic weight management in eligible adults. Continue Reading
Blog 18 November 2026 Five days of easier meal decisions Discover five days of realistic meal ideas designed to help you enjoy a variety of foods, save time in the kitchen, and make nutritious choices with less stress and planning. Continue Reading